SCHEMBL6071928

SCHEMBL6071928

C[C](C)Cc1ccc(F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.43
POLB P06746 1/20 0.43
P2RX7 Q99572 9/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HTT P42858 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
ALOX15 P16050 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24173290 0.85 L3MBTL1 (0.48) L3MBTL1POLBP2RX7SMN1; SMN2CYP1A2
SCHEMBL30941510 0.85 L3MBTL1 (0.48) L3MBTL1POLBP2RX7SMN1; SMN2CYP1A2
SCHEMBL435206 0.79 IDO1 (0.54) P2RX7CYP1A2CYP2C19HTTALDH1A1
SCHEMBL434355 0.79 IDO1 (0.48) P2RX7SMN1; SMN2ALDH1A1KDM4E
SCHEMBL837008 0.78 ALDH1A1 (0.46) L3MBTL1POLBP2RX7CYP1A2CYP2C19
SCHEMBL30911087 0.78 MEN1 (0.52) L3MBTL1POLBP2RX7CYP1A2CYP2C19
SCHEMBL1699587 0.78 MEN1 (0.52) L3MBTL1POLBP2RX7CYP1A2CYP2C19
SCHEMBL10122957 0.78 CYP2C19 (0.43) L3MBTL1POLBP2RX7SMN1; SMN2CYP1A2
SCHEMBL29718887 0.77 ALDH1A1 (0.44) L3MBTL1POLBP2RX7CYP1A2CYP2C19
SCHEMBL1395757 0.77 ALDH1A1 (0.44) L3MBTL1POLBP2RX7CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016026830-A1 NOVEL FUNGICIDAL PYRAZOLE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-02-25 WO disclosed
US-20060160794-A1 Tachykinin receptor antagonists ELI LILLY AND COMPANY 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160794-A1 Tachykinin receptor antagonists TACR1, TACR2, PROKR1 L3MBTL1 3797/4885POLB 4829/4885P2RX7 685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.